Related Experiment Video
Updated: Jun 12, 2026

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia
Nicholas Ah Mew1, Robert McCarter, Yevgeny Daikhin
1Research Center for Genetic Medicine, Children's National Medical Center, George Washington University, Washington, DC 20010, USA.
Objectives:
The objective of this study was to determine whether N-carbamylglutamate (NCG) reduces plasma levels of ammonia and glutamine and increases the rate of ureagenesis in patients with propionic acidemia (PA).
Methods:
Identical 4-hour studies were performed before and immediately after a 3-day trial of oral NCG in 7 patients with PA. An oral bolus of [(13)C]sodium acetate was administered at the start of each study, and sequential blood samples were obtained to measure [(13)C]urea, ammonia, urea, and amino acids.
Results:
With longitudinal mixed-effects linear regression, peak [(13)C]urea increased after treatment with NCG (from 2.2 to 3.8 microM; P < .0005). There were concomitant decreases in mean plasma ammonia (59-43 microM; P < .018) and glutamine (552-331 microM; P < .0005).
Conclusions:
NCG augments ureagenesis and decreases plasma ammonia and glutamine in patients with PA. The drug may serve as an important therapeutic adjunct in the treatment of acute hyperammonemia in this disorder.
Related Concept Videos
Urea Cycle
Amino Acid Biosynthetic Pathways
Inborn Errors of Metabolism
Inorganic Nitrogen Assimilation
Antiepileptic Drugs: Glutamate Antagonists
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...

